.jpg "Teresa A. Simon, MPH photo")
Owner/CEO
Physicians Research Center,LLC
Teresa Simon, MPH, Owner and CEO of Physicians Research Center, a company focused on education, data analytics and clinical studies.
www.prc-trials-plus.com. With over 25 years of experience in clinical practice, health outcomes, and epidemiology in cardiovascular, rheumatic diseases,cannabis and psychedelics. Simon’s career has included pre- and post-marketing epidemiologic strategic guidance to academics, pharma and regulatory bodies. She has designed real-world studies to evaluate health outcomes, patient experience, safety-related outcomes, and economic evaluations. Ms. Simon works with academic centers worldwide to implement studies that use observational and patient experience data to detect, quantify and characterize safety signals that is used to inform the benefits and risks of medicines. Simon holds a graduate-level medical cannabis certificate from Jefferson University. Most recent projects include education programs developed for healthcare providers and students on cannabis and psychedelic treatments. Simon is a connector with a passion for providing clear and concise information to patients, healthcare providers, and our youth.
A few publications are listed below:
1. Simon TA, Simon JH, Heaning EG, Gomez-Caminero A, Marcu JP. Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer: Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Drug Healthc Patient Saf. 2023 Jan 29;15:25-38
2. Marcu J, Simon TA, Molloy P. A New Ache in the World of Joints. Arch of Rheum and Arthritis Res. 2021 Aug.
3. Wipfler K, Simon TA, Katz P, Wolfe F, Michaud K. Increase in Cannabis Use Among Adults with Rheumatic Diseases: Results from a 2014-2019 US Observational Study. Arthritis Care Res; 2021 Jul 15.
4. Simon TA, Khouri MS, Kou TD, Gomez-Caminero A. Realizing The Potential of the Patient Perspective. Patient Prefer Adherence. 2020 Oct 22;14:2001-2007.
6. Simon TA. High-quality cooperative research: studies that represent a triumph in the rheumatology community. Arthritis Research and Therapy 2019 Nov, 11:21:232.
